SciCombinator

Discover the most talked about and latest scientific content & concepts.

EB Geer, J Sisco, DT Adelman, WH Ludlam, A Haviv, D Gelbaum, S Liu, SD Mathias and L Shi
Abstract
Acromegaly patients, even those with IGF-1 values within the normal range receiving somatostatin receptor ligands (SRLs), often suffer from significant symptoms. It is not known to what extent patients' medical providers are aware of the frequency and severity of acromegaly symptoms or level of treatment satisfaction with SRLs. This study sought to examine the concordance between outcomes reported by acromegaly patients treated with long-acting SRLs and those perceived by their medical provider.
Tweets*
6
Facebook likes*
0
Reddit*
0
News coverage*
3
Blogs*
0
SC clicks
0
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com